exhibit 10. 37 confidential materials omitted and filed separately with the securities and exchange commission. double asterisks denote omissions. licensing and commercialization agreement by and between spark therapeutics, inc. and novartis pharma ag january 24, 2018 activeus 166647742v. 1 table of contents definitions ; interpretation1 definitions ; interpretation definitions ; interpretation 1 1 1. 1definitions 1 1. 2additional definitions 11 1. 3interpretation 12 governance13 governance governance 13 13 2. 1joint steering committee 13 2. 2alliance managers 15 licenses ; options ; other rights15 licenses ; options ; other rights licenses ; options ; other rights 15 15 3. 1grants by spark 15 3. 2grants by novartis 17 3. 3section 365 ( n ) of the u. s. bankruptcy code 19 development, technical development and regulatory activities20 development, technical development and regulatory activities development, technical development and regulatory activities 20 20 4. 1general 20 4. 2development plan 21 4. 3development studies 22 4. 4regulatory activities 23 4. 5adverse event and product complaint reporting procedures ; pharmacovigilance 25 4. 6decisions to terminate or suspend a study based on safety concerns 25 commercialization26 commercialization commercialization 26 26 5. 1diligence 26 5. 2product trademarks 26 5. 3advertising and promotional materials 26 5. 4pricing and reimbursement 26 5. 5other responsibilities 27 5. 6manufacture and supply 27 financial provisions27 financial provisions financial provisions 27 27 6. 1upfront payments 27 6. 2milestones 27 6. 3royalties 28 6. 4reports ; invoices ; payments 28 6. 5records ; audits 28 6. 6tax matters 29 6. 7currency exchange 29 6. 8blocked payments 29 6. 9late payments 29 6. 10resolution of disputes 30 6. 11no guarantee 30 intellectual property ownership, protection and related matters30 intellectual property ownership, protection and related matters intellectual property ownership, protection and related matters 30 30 7. 1ownership of intellectual property 30 7. 2handling of patent rights 31 7. 3third party infringement 31 7. 4claimed infringement 34 7. 5patent term extensions 34 7. 6license